Synovial sarcomas develop secondary to a unique chromosomal translocation t(X;18)(p11;q11) involving SS18, SSX1, SSX2 or SSX4 genes resulting in a characteristic SS18-SSX fusion [2,3]. This evidence concerns the gene SSX2 and synovial sarcoma.